Renvela Sales Data
| Rank 76 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Renvela U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 76 ( 7) |
$210,975 | 4.77% | 354 | -1.39% |
| Q4 2012 | 83 (9) |
$201,365 | 9.62% | 359 | 13.61% |
| Q3 2012 | 92 (2) |
$183,699 | 7.39% | 316 | 7.48% |
| Q2 2012 | 94 ( ) |
$171,055 |  |
294 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
